Connection

James Ballenger to Anxiety Disorders

Back to Details
This is a "connection" page, showing publications James Ballenger has written about Anxiety Disorders.
James Ballenger
Connection Strength
3.852
Anxiety Disorders
  1. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.239
  2. Remission rates in patients with anxiety disorders treated with paroxetine. J Clin Psychiatry. 2004 Dec; 65(12):1696-707.
    View in: PubMed
    Score: 0.190
  3. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001; 62 Suppl 11:53-8.
    View in: PubMed
    Score: 0.145
  4. Treatment of anxiety disorders to remission. J Clin Psychiatry. 2001; 62 Suppl 12:5-9.
    View in: PubMed
    Score: 0.145
  5. Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001; 62 Suppl 13:47-55.
    View in: PubMed
    Score: 0.145
  6. Consensus statement on depression, anxiety, and cardiovascular disease. J Clin Psychiatry. 2001; 62 Suppl 8:24-7.
    View in: PubMed
    Score: 0.145
  7. Consensus statement on depression, anxiety, and functional gastrointestinal disorders. J Clin Psychiatry. 2001; 62 Suppl 8:48-51.
    View in: PubMed
    Score: 0.145
  8. Consensus statement on depression, anxiety, and oncology. J Clin Psychiatry. 2001; 62 Suppl 8:64-7.
    View in: PubMed
    Score: 0.145
  9. Structural issues and policy in the management of depressive illness. Overview and expert panel commentary. Eur Neuropsychopharmacol. 2000 Dec; 10 Suppl 4:S449-53.
    View in: PubMed
    Score: 0.144
  10. Current treatments of the anxiety disorders in adults. Biol Psychiatry. 1999 Dec 01; 46(11):1579-94.
    View in: PubMed
    Score: 0.134
  11. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry. 1999; 60 Suppl 22:29-34.
    View in: PubMed
    Score: 0.126
  12. Translational implications of the amygdala-stria terminalis model for the clinical anxiety disorders. Biol Psychiatry. 1998 Dec 15; 44(12):1204-7.
    View in: PubMed
    Score: 0.125
  13. Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry. 1998 Jun 01; 43(11):840-2.
    View in: PubMed
    Score: 0.121
  14. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry. 1997 May; 154(5):700-2.
    View in: PubMed
    Score: 0.112
  15. Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 1996 Aug; 64(4):660-8.
    View in: PubMed
    Score: 0.106
  16. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7.
    View in: PubMed
    Score: 0.101
  17. Plasma pyridoxal phosphate in anxiety disorders. Biol Psychiatry. 1994 Nov 01; 36(9):606-8.
    View in: PubMed
    Score: 0.094
  18. Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders. Am J Psychiatry. 1994 Jun; 151(6):930-2.
    View in: PubMed
    Score: 0.092
  19. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug; 150(8):1216-8.
    View in: PubMed
    Score: 0.086
  20. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder. Adv Biochem Psychopharmacol. 1992; 47:431-47.
    View in: PubMed
    Score: 0.077
  21. Effect of alprazolam on depression in panic disorder. J Clin Psychopharmacol. 1991 Apr; 11(2):145-6.
    View in: PubMed
    Score: 0.074
  22. Long-term pharmacologic treatment of panic disorder. J Clin Psychiatry. 1991 Feb; 52 Suppl:18-23; discussion 24-5.
    View in: PubMed
    Score: 0.073
  23. Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. J Clin Psychiatry. 1991 Feb; 52 Suppl:26-31; discussion 32.
    View in: PubMed
    Score: 0.073
  24. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder. Psychopharmacol Bull. 1991; 27(2):171-9.
    View in: PubMed
    Score: 0.072
  25. Panic and phobic disorders in patients with obsessive compulsive disorder. J Clin Psychiatry. 1990 Nov; 51(11):456-8.
    View in: PubMed
    Score: 0.071
  26. Efficacy of benzodiazepines in panic disorder and agoraphobia. J Psychiatr Res. 1990; 24 Suppl 2:15-25.
    View in: PubMed
    Score: 0.067
  27. Depression in patients receiving lorazepam for panic. Am J Psychiatry. 1989 Sep; 146(9):1230-1.
    View in: PubMed
    Score: 0.066
  28. Toward an integrated model of panic disorder. Am J Orthopsychiatry. 1989 Apr; 59(2):284-93.
    View in: PubMed
    Score: 0.064
  29. Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp Community Psychiatry. 1988 Nov; 39(11):1157-65.
    View in: PubMed
    Score: 0.062
  30. Possible relationship of bowel obsessions to panic disorder with agoraphobia. Am J Psychiatry. 1988 Oct; 145(10):1324-5.
    View in: PubMed
    Score: 0.062
  31. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry. 1988 May; 45(5):413-22.
    View in: PubMed
    Score: 0.060
  32. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry. 1986 Sep; 47(9):470-3.
    View in: PubMed
    Score: 0.054
  33. Pharmacotherapy of the panic disorders. J Clin Psychiatry. 1986 Jun; 47 Suppl:27-32.
    View in: PubMed
    Score: 0.053
  34. Biological aspects of panic disorder. Am J Psychiatry. 1986 Apr; 143(4):516-8.
    View in: PubMed
    Score: 0.052
  35. Psychopharmacology of the anxiety disorders. Psychiatr Clin North Am. 1984 Dec; 7(4):757-71.
    View in: PubMed
    Score: 0.047
  36. Generalized anxiety disorder: comorbidity, comparative biology and treatment. Int J Neuropsychopharmacol. 2002 Dec; 5(4):315-25.
    View in: PubMed
    Score: 0.041
  37. Recognizing the patient with social anxiety disorder. Int Clin Psychopharmacol. 2000 Jul; 15 Suppl 1:S1-5.
    View in: PubMed
    Score: 0.035
  38. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999 Jul; 60(7):427-35.
    View in: PubMed
    Score: 0.033
  39. Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 17:54-60.
    View in: PubMed
    Score: 0.029
  40. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. J Clin Psychiatry. 1997; 58 Suppl 11:11-8.
    View in: PubMed
    Score: 0.027
  41. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biol Psychiatry. 1996 Apr 15; 39(8):703-7.
    View in: PubMed
    Score: 0.026
  42. Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry. 1995 Feb; 56(2):77-80.
    View in: PubMed
    Score: 0.024
  43. Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders. J Neuropsychiatry Clin Neurosci. 1993; 5(3):335-7.
    View in: PubMed
    Score: 0.021
  44. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry. 1988 May; 45(5):423-8.
    View in: PubMed
    Score: 0.015
  45. Alprazolam in the treatment of social phobia. J Clin Psychiatry. 1988 Jan; 49(1):17-9.
    View in: PubMed
    Score: 0.015
  46. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry. 1987 May; 144(5):664-5.
    View in: PubMed
    Score: 0.014
  47. Infrequent panic attacks: psychiatric comorbidity, personality characteristics and functional disability. J Psychiatr Res. 1995 Mar-Apr; 29(2):121-31.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.